We are live on ! Find out more
GC

Grace Capital Portfolio holdings

AUM $168M
1-Year Est. Return 21.6%
This Fund
S&P 500
This Quarter Est. Return
+18.02%
1 Year Est. Return
+21.6%
3 Year Est. Return
+126.68%
5 Year Est. Return
+161.89%
10 Year Est. Return
–
AUM
$256M
AUM Growth
+$40.8M
Cap. Flow
+$11.8M
Cap. Flow %
4.61%
Top 10 Hldgs %
25.74%
Holding
236
New
24
Increased
57
Reduced
82
Closed
36

Top Buys

Rank Stock Value
1
GBT
Global Blood Therapeutics, Inc.
GBT
+$8.05M
2
IBM icon
IBM
IBM
+$3.95M
3
VHT icon
Vanguard Health Care ETF
VHT
+$3.42M
4
VCR icon
Vanguard Consumer Discretionary ETF
VCR
+$3.18M
5
VOX icon
Vanguard Communication Services ETF
VOX
+$3.16M

Top Sells

Rank Stock Value
1
MYOK
MyoKardia, Inc. Common Stock
MYOK
+$4.09M
2
GNTX icon
Gentex
GNTX
+$1.95M
3
SIRI icon
SiriusXM
SIRI
+$1.89M
4
VRSN icon
VeriSign
VRSN
+$1.63M
5
NVS icon
Novartis
NVS
+$1.39M

Sector Composition

Rank Sector Weight
1 Technology 17.16%
2 Healthcare 16.63%
3 Financials 9.69%
4 Consumer Discretionary 8.9%
5 Communication Services 6.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CLB icon
176
Core Laboratories
CLB
$538M
$117K 0.05%
1,700
– –
WMB icon
177
Williams Companies
WMB
$90.5B
$115K 0.04%
4,000
-4,600
-53% -$123K
BOND icon
178
PIMCO Active Bond Exchange-Traded Fund
BOND
$8.28B
$106K 0.04%
1,000
– –
NOV icon
179
NOV
NOV
$7.45B
$105K 0.04%
2,000
+200
+11% +$5.67K
LIVN icon
180
LivaNova
LIVN
$4.3B
$97K 0.04%
1,000
-800
-44% -$74.7K
TT icon
181
Trane Technologies
TT
$106B
$97K 0.04%
900
– –
BFH icon
182
Bread Financial
BFH
$4.21B
$87K 0.03%
627
-250
-29% -$34K
TCOM icon
183
Trip.com Group
TCOM
$27.5B
$87K 0.03%
2,000
-3,000
-60% -$105K
IBB icon
184
iShares Biotechnology ETF
IBB
$9.31B
$84K 0.03%
750
– –
FOMX
185
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$83K 0.03%
10,700
-29,300
-73% -$110K
DGRO icon
186
iShares Core Dividend Growth ETF
DGRO
$42.6B
$80K 0.03%
2,185
+455
+26% +$16.2K
MOO icon
187
VanEck Agribusiness ETF
MOO
$989M
$75K 0.03%
+1,200
New +$73.4K
OVV icon
188
Ovintiv
OVV
$17.5B
$72K 0.03%
+1,977
New +$67.8K
KO icon
189
Coca-Cola
KO
$354B
$71K 0.03%
1,520
– –
DVN icon
190
Devon Energy
DVN
$51.9B
$63K 0.02%
+2,000
New +$55.9K
CVX icon
191
Chevron
CVX
$388B
$62K 0.02%
500
– –
XLE icon
192
State Street Energy Select Sector SPDR ETF
XLE
$39.5B
$33K 0.01%
1,000
– –
AR icon
193
Antero Resources
AR
$10.9B
$26K 0.01%
3,000
– –
MMP
194
DELISTED
Magellan Midstream Partners, L.P.
MMP
$23K 0.01%
378
– –
NUE icon
195
Nucor
NUE
$56.4B
$18K 0.01%
300
– –
ABT icon
196
Abbott
ABT
$180B
$12K ﹤0.01%
150
– –
EFOR
197
Everforth Inc
EFOR
$845M
– –
-6,384
Closed -$348K
BPMC
198
DELISTED
Blueprint Medicines
BPMC
– –
-2,696
Closed -$145K
CACI icon
199
CACI
CACI
$10.8B
– –
-3,486
Closed -$502K
CI icon
200
Cigna
CI
$76.6B
– –
-875
Closed -$166K
6 7
8
9 10

Similar funds

REMS
Real Estate Management Services $167M AUM 37.69% 1-Year Est. Return
TI
Truehand Inc Strafford, New Hampshire $171M AUM 25.9% 1-Year Est. Return
NM
Nokota Management New York $165M AUM
KM
Kylin Management New York $173M AUM 39.51% 1-Year Est. Return
MC
MRJ Capital New York $173M AUM 31.99% 1-Year Est. Return
FAC
Forrestal Agricultural Corporation Princeton, New Jersey $183M AUM
MSO
Madryn Select Opportunities New York $150M AUM
ACM
Asymmetry Capital Management San Francisco, California $188M AUM 44.72% 1-Year Est. Return

Grace Capital's Q1 2019 Portfolio in Review

As of Q1 2019, Grace Capital held 236 positions worth $256M, up 19% from $215M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Grace Capital deployed $11.8M of net new capital in Q1 2019, opening 24 new positions and adding to 57 existing holdings. Its largest new stake was IBM: 30,988 shares worth $4.18M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was MyoKardia, Inc. Common Stock, an estimated $4.09M trimmed.

  • Grace Capital's largest Q1 2019 buy was IBM: 30,988 shares worth $4.18M.
  • Grace Capital added most to Global Blood Therapeutics, Inc. in Q1 2019, an estimated $8.05M increase.
  • Grace Capital's biggest Q1 2019 reduction was MyoKardia, Inc. Common Stock, cutting an estimated $4.09M.
  • Grace Capital fully exited Gentex in Q1 2019, selling an estimated $1.95M.
  • Grace Capital's ten largest holdings make up 26% of its $256M portfolio in Q1 2019.
  • Grace Capital opened 24 new positions and closed 36 in Q1 2019.
  • Grace Capital's portfolio value rose 19% quarter-over-quarter to $256M.

Based on Grace Capital's 13F filing for Q1 2019, filed 15 May 2019.